1932

Abstract

Despite unequivocal evidence that folate deficiency increases risk for human pathologies, and that folic acid intake among women of childbearing age markedly decreases risk for birth defects, definitive evidence for a causal biochemical pathway linking folate to disease and birth defect etiology remains elusive. The de novo and salvage pathways for thymidylate synthesis translocate to the nucleus of mammalian cells during S- and G2/M-phases of the cell cycle and associate with the DNA replication and repair machinery, which limits uracil misincorporation into DNA and genome instability. There is increasing evidence that impairments in nuclear de novo thymidylate synthesis occur in many pathologies resulting from impairments in one-carbon metabolism. Understanding the roles and regulation of nuclear de novo thymidylate synthesis and its relationship to genome stability will increase our understanding of the fundamental mechanisms underlying folate- and vitamin B–associated pathologies.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-nutr-071714-034441
2018-08-21
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/nutr/38/1/annurev-nutr-071714-034441.html?itemId=/content/journals/10.1146/annurev-nutr-071714-034441&mimeType=html&fmt=ahah

Literature Cited

  1. 1.  Abali EE, Skacel NE, Celikkaya H, Hsieh YC 2008. Regulation of human dihydrofolate reductase activity and expression. Vitam. Horm. 79:267–92
    [Google Scholar]
  2. 2.  Ames BN 2001. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat. Res. 475:7–20
    [Google Scholar]
  3. 3.  An S, Kumar R, Sheets ED, Benkovic SJ 2008. Reversible compartmentalization of de novo purine biosynthetic complexes in living cells. Science 320:103–6
    [Google Scholar]
  4. 4.  Andersen S, Heine T, Sneve R, Konig I, Krokan HE et al. 2005. Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts. Carcinogenesis 26:547–55
    [Google Scholar]
  5. 5.  Anderson DD, Eom JY, Stover PJ 2012. Competition between sumoylation and ubiquitination of serine hydroxymethyltransferase 1 determines its nuclear localization and its accumulation in the nucleus. J. Biol. Chem. 287:4790–99
    [Google Scholar]
  6. 6.  Anderson DD, Stover PJ 2009. SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis. PLOS ONE 4:e5839
    [Google Scholar]
  7. 7.  Anderson DD, Woeller CF, Chiang EP, Shane B, Stover PJ 2012. Serine hydroxymethyltransferase anchors de novo thymidylate synthesis pathway to nuclear lamina for DNA synthesis. J. Biol. Chem. 287:7051–62
    [Google Scholar]
  8. 8.  Anderson DD, Woeller CF, Stover PJ 2007. Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase. Clin. Chem. Lab. Med. 45:1760–63
    [Google Scholar]
  9. 9.  Appleman JR, Prendergast N, Delcamp TJ, Freisheim JH, Blakley RL 1988. Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase. J. Biol. Chem. 263:10304–13
    [Google Scholar]
  10. 10.  Banka S, Blom HJ, Walter J, Aziz M, Urquhart J et al. 2011. Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am. J. Hum. Genet. 88:216–25
    [Google Scholar]
  11. 11.  Beaudin AE, Abarinov EV, Malysheva O, Perry CA, Caudill M, Stover PJ 2012. Dietary folate, but not choline, modifies neural tube defect risk in Shmt1 knockout mice. Am. J. Clin. Nutr. 95:109–14
    [Google Scholar]
  12. 12.  Beaudin AE, Abarinov EV, Noden DM, Perry CA, Chu S et al. 2011. Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. Am. J. Clin. Nutr. 93:789–98
    [Google Scholar]
  13. 13.  Beaudin AE, Perry CA, Stabler SP, Allen RH, Stover PJ 2012. Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice. Am. J. Clin. Nutr. 95:882–91
    [Google Scholar]
  14. 14.  Beaudin AE, Stover PJ 2009. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res. A Clin. Mol. Teratol. 85:274–84
    [Google Scholar]
  15. 15.  Bertino JR, Donohue DR, Gabrio BW, Silber R, Alenty A et al. 1962. Increased level of dihydrofolic reductase in leucocytes of patients treated with amethopterin. Nature 193:140–42
    [Google Scholar]
  16. 16.  Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA et al. 1997. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. PNAS 94:3290–95
    [Google Scholar]
  17. 17.  Bolusani S, Young BA, Cole NA, Tibbetts AS, Momb J et al. 2011. Mammalian MTHFD2L encodes a mitochondrial methylenetetrahydrofolate dehydrogenase isozyme expressed in adult tissues. J. Biol. Chem. 286:5166–74
    [Google Scholar]
  18. 18.  Boorstein RJ, Pardee AB 1983. Coordinate inhibition of DNA synthesis and thymidylate synthase activity following DNA damage and repair. Biochem. Biophys. Res. Commun. 117:30–36
    [Google Scholar]
  19. 19.  Bower C, Stanley FJ 1989. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med. J. Aust. 150:613–19
    [Google Scholar]
  20. 20.  Brody LC, Conley M, Cox C, Kirke PN, McKeever MP et al. 2002. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am. J. Hum. Genet. 71:1207–15
    [Google Scholar]
  21. 21.  Brown SS, Neal GE, Williams DC 1965. Subcellular distribution of some folic acid-linked enzymes in rat liver. Biochem. J. 97:34C–36C
    [Google Scholar]
  22. 22.  Budai B, Komlosi V, Adleff V, Pap E, Reti A et al. 2012. Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab. Pharmacogenet. Genom. 22:69–72
    [Google Scholar]
  23. 23.  Burda P, Kuster A, Hjalmarson O, Suormala T, Burer C et al. 2015. Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment. J. Inherit. Metab. Dis. 38:863–72
    [Google Scholar]
  24. 24.  Bystroff C, Kraut J 1991. Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. Biochemistry 30:2227–39
    [Google Scholar]
  25. 25.  Cario H, Smith DE, Blom H, Blau N, Bode H et al. 2011. Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am. J. Hum. Genet. 88:226–31
    [Google Scholar]
  26. 26.  Carozzi VA, Canta A, Chiorazzi A 2015. Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?. Neurosci. Lett. 596:90–107
    [Google Scholar]
  27. 27.  Castilla EE, Orioli IM, Lopez-Camelo JS, Graça Dutra M, Nazer-Herrera J 2003. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am. J. Med. Genet. 123A:123–28
    [Google Scholar]
  28. 28.  Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP et al. 1996. S-adenosylmethionine and methylation. FASEB J 10:471–80
    [Google Scholar]
  29. 29.  Chiba P, Bacon PE, Cory JG 1984. Studies directed toward testing the “channeling” hypothesis–ribonucleotides—DNA in leukemia L1210 cells. Biochem. Biophys. Res. Commun. 123:656–62
    [Google Scholar]
  30. 30.  Choi SW, Mason JB 2000. Folate and carcinogenesis: an integrated scheme. J. Nutr. 130:129–32
    [Google Scholar]
  31. 31.  Chon J, Stover PJ, Field MS 2017. Targeting nuclear thymidylate biosynthesis. Mol. Aspects Med. 53:48–56
    [Google Scholar]
  32. 32.  Clarke S, Banfield K 2001. S-adenosylmethionine-dependent methyltransferases. Homocysteine in Health and Disease R Carmel, DW Jacobson 63–78 Cambridge, UK: Cambridge Univ. Press
    [Google Scholar]
  33. 33.  Crider KS, Devine O, Hao L, Dowling NF, Li S et al. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349:g4554
    [Google Scholar]
  34. 34.  Czeizel AE, Dudas I 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1832–35
    [Google Scholar]
  35. 35.  DebRoy S, Kramarenko II, Ghose S, Oleinik NV, Krupenko SA, Krupenko NI 2013. A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization. PLOS ONE 8:e70062
    [Google Scholar]
  36. 36.  Delgado M, Garrido F, Pérez-Miguelsanz J, Pacheco M, Partearroyo T et al. 2014. Acute liver injury induces nucleocytoplasmic redistribution of hepatic methionine metabolism enzymes. Antioxid. Redox Signal. 20:2541–54
    [Google Scholar]
  37. 37.  Dror DK, Allen LH 2012. Interventions with vitamins B6, B12 and C in pregnancy. Paediatr. Perinat. Epidemiol. 26:Suppl. 155–74
    [Google Scholar]
  38. 38.  Felkner M, Suarez L, Canfield MA, Brender JD, Sun Q 2009. Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population. Birth Defects Res. A Clin. Mol. Teratol. 85:574–81
    [Google Scholar]
  39. 39.  Field MS, Anderson DD, Stover PJ 2011. Mthfs is an essential gene in mice and a component of the purinosome. Front. Genet. 2:36
    [Google Scholar]
  40. 40.  Field MS, Kamynina E, Agunloye OC, Liebenthal RP, Lamarre SG et al. 2014. Nuclear enrichment of folate cofactors and methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) protect de novo thymidylate biosynthesis during folate deficiency. J. Biol. Chem. 289:29642–50
    [Google Scholar]
  41. 41.  Field MS, Kamynina E, Watkins D, Rosenblatt DS, Stover PJ 2015. Human mutations in methylenetetrahydrofolate dehydrogenase 1 impair nuclear de novo thymidylate biosynthesis. PNAS 112:400–5
    [Google Scholar]
  42. 42.  Field MS, Kamynina E, Watkins D, Rosenblatt DS, Stover PJ 2015. New insights into the metabolic and nutritional determinants of severe combined immunodeficiency. Rare Dis 3:e1112479
    [Google Scholar]
  43. 43.  Field MS, Stover PJ 2018. Safety of folic acid. Ann. N. Y. Acad. Sci. 1414:59–71
    [Google Scholar]
  44. 44.  Fox JT, Stover PJ 2008. Folate-mediated one-carbon metabolism. Vitam. Horm. 79:1–44
    [Google Scholar]
  45. 45.  Friso S, Choi SW, Dolnikowski GG, Selhub J 2002. A method to assess genomic DNA methylation using high-performance liquid chromatography/electrospray ionization mass spectrometry. Anal. Chem. 74:4526–31
    [Google Scholar]
  46. 46.  Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG et al. 2002. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. PNAS 99:5606–11
    [Google Scholar]
  47. 47.  Froese DS, Wu X, Zhang J, Dumas R, Schoel WM et al. 2008. Restricted role for methionine synthase reductase defined by subcellular localization. Mol. Genet. Metab. 94:68–77
    [Google Scholar]
  48. 48.  Gaber KR, Farang MK, Soliman SE, El-Bassyouni HT, El-Kamah G 2007. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin. Lab. 53:69–75
    [Google Scholar]
  49. 49.  Gonen N, Assaraf YG 2012. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist. Updates 15:183–210
    [Google Scholar]
  50. 50.  Green JM, MacKenzie RE, Matthews RG 1988. Substrate flux through methylenetetrahydrofolate dehydrogenase: predicted effects of the concentration of methylenetetrahydrofolate on its partitioning into pathways leading to nucleotide biosynthesis or methionine regeneration. Biochemistry 27:8014–22
    [Google Scholar]
  51. 51.  Groenen PM, van Rooij IA, Peer PG, Gooskens RH, Zielhuis GA, Steegers-Theunissen RP 2004. Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am. J. Obstet. Gynecol. 191:11–17
    [Google Scholar]
  52. 52.  Gu Q, Li Y, Cui ZL, Luo XP 2012. Homocysteine, folate, vitamin B12 and B6 in mothers of children with neural tube defects in Xinjiang, China. Acta Paediatr 101:e486–90
    [Google Scholar]
  53. 53.  Hendriks IA, Vertegaal AC 2016. A comprehensive compilation of SUMO proteomics. Nat. Rev. Mol. Cell Biol. 17:581–95
    [Google Scholar]
  54. 54.  Herbig K, Chiang EP, Lee LR, Hills J, Shane B, Stover PJ 2002. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J. Biol. Chem. 277:38381–89
    [Google Scholar]
  55. 55.  Hibbard BM 1964. The role of folic acid in pregnancy; with particular reference to anaemia, abruption and abortion. J. Obstet. Gynaecol. Br. Commonw. 71:529–42
    [Google Scholar]
  56. 56.  Hibbard BM 1967. Defective folate metabolism in pathological conditions of pregnancy. Acta Obstet. Gynecol. Scand. 46:Suppl. 747–59
    [Google Scholar]
  57. 57.  Hoffbrand AV, Weir DG 2001. The history of folic acid. Br. J. Haematol. 113:579–89
    [Google Scholar]
  58. 58.  Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL et al. 2011. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 378:584–94
    [Google Scholar]
  59. 59.  Huang C, Sloan EA, Boerkoel CF 2003. Chromatin remodeling and human disease. Curr. Opin. Genet. Dev. 13:246–52
    [Google Scholar]
  60. 60.  Igarashi K, Katoh Y 2013. Metabolic aspects of epigenome: coupling of S-adenosylmethionine synthesis and gene regulation on chromatin by SAMIT module. Subcell. Biochem. 61:105–18
    [Google Scholar]
  61. 61.  Jaenisch R, Bird A 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33:Suppl.245–54
    [Google Scholar]
  62. 62.  Kamynina E, Lachenauer ER, DiRisio AC, Liebenthal RP, Field MS, Stover PJ 2017. Arsenic trioxide targets MTHFD1 and SUMO-dependent nuclear de novo thymidylate biosynthesis. PNAS 114:E2319–26
    [Google Scholar]
  63. 63.  Kapiszewska M, Kalemba M, Wojciech U, Milewicz T 2005. Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J. Nutr. Biochem. 16:467–78
    [Google Scholar]
  64. 64.  Keller MD, Ganesh J, Heltzer M, Paessler M, Bergqvist AG et al. 2013. Severe combined immunodeficiency resulting from mutations in MTHFD1. . Pediatrics 131:e629–34
    [Google Scholar]
  65. 65.  Kim YI 1999. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr. Rev. 57:314–21
    [Google Scholar]
  66. 66.  Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med. 86:703–8
    [Google Scholar]
  67. 67.  Kronenberg G, Gertz K, Overall RW, Harms C, Klein J et al. 2011. Folate deficiency increases mtDNA and D-1 mtDNA deletion in aged brain of mice lacking uracil-DNA glycosylase. Exp. Neurol. 228:253–58
    [Google Scholar]
  68. 68.  Krupenko NI, Wagner C 1997. Transport of rat liver glycine N-methyltransferase into rat liver nuclei. J. Biol. Chem. 272:27140–46
    [Google Scholar]
  69. 69.  Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K et al. 2014. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312:729–38
    [Google Scholar]
  70. 70.  Li D, Pickell L, Liu Y, Wu Q, Cohn JS, Rozen R 2005. Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am. J. Clin. Nutr. 82:188–95
    [Google Scholar]
  71. 71.  Longley DB, Harkin DP, Johnston PG 2003. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3:330–38
    [Google Scholar]
  72. 72.  Luka Z, Mudd SH, Wagner C 2009. Glycine N-methyltransferase and regulation of S-adenosylmethionine levels. J. Biol. Chem. 284:22507–11
    [Google Scholar]
  73. 73.  MacFarlane AJ, Anderson DD, Flodby P, Perry CA, Allen RH et al. 2011. Nuclear localization of de novo thymidylate biosynthesis pathway is required to prevent uracil accumulation in DNA. J. Biol. Chem. 286:44015–22
    [Google Scholar]
  74. 74.  MacFarlane AJ, Greene-Finestone LS, Shi Y 2011. Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey. Am. J. Clin. Nutr. 94:1079–87
    [Google Scholar]
  75. 75.  MacFarlane AJ, Liu X, Perry CA, Flodby P, Allen RH et al. 2008. Cytoplasmic serine hydroxymethyltransferase regulates the metabolic partitioning of methylenetetrahydrofolate but is not essential in mice. J. Biol. Chem. 283:25846–53
    [Google Scholar]
  76. 76.  MacFarlane AJ, McEntee MF, Stover PJ 2014. Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity. J. Nutr. 144:419–24
    [Google Scholar]
  77. 77.  MacFarlane AJ, Perry CA, Girnary HH, Gao D, Allen RH et al. 2009. Mthfd1 is an essential gene in mice and alters biomarkers of impaired one-carbon metabolism. J. Biol. Chem. 284:1533–39
    [Google Scholar]
  78. 78.  MacFarlane AJ, Perry CA, McEntee MF, Lin DM, Stover PJ 2011. Mthfd1 is a modifier of chemically induced intestinal carcinogenesis. Carcinogenesis 32:427–33
    [Google Scholar]
  79. 79.  MacFarlane AJ, Perry CA, McEntee MF, Lin DM, Stover PJ 2011. Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apcmin-mediated intestinal cancer risk. Cancer Res 71:2098–107
    [Google Scholar]
  80. 80.  MacFarlane AJ, Stover PJ 2007. Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers. Nutr. Rev. 65:S157–66
    [Google Scholar]
  81. 81.  Mason JB 2011. Unraveling the complex relationship between folate and cancer risk. Biofactors 37:253–60
    [Google Scholar]
  82. 82.  Mason JB, Choi SW 2000. The mechanisms by which folate depletion enhances colorectal carcinogenesis: a unified scheme. Nestle Nutr. Workshop Ser. Clin. Perform. Programme 4:87–99
    [Google Scholar]
  83. 83.  Mato JM, Martínez-Chantar ML, Lu SC 2008. Methionine metabolism and liver disease. Annu. Rev. Nutr. 28:273–93
    [Google Scholar]
  84. 84.  McCarthy EA, Titus SA, Taylor SM, Jackson-Cook C, Moran RG 2004. A mutation inactivating the mitochondrial inner membrane folate transporter creates a glycine requirement for survival of Chinese hamster cells. J. Biol. Chem. 279:33829–36
    [Google Scholar]
  85. 85.  Mellman I, Willard HF, Rosenberg LE 1978. Cobalamin binding and cobalamin-dependent enzyme activity in normal and mutant human fibroblasts. J. Clin. Investig. 62:952–60
    [Google Scholar]
  86. 86.  Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149–51
    [Google Scholar]
  87. 87.  Mills JL, Signore C 2004. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res. A Clin. Mol. Teratol. 70:844–45
    [Google Scholar]
  88. 88.  Mills JL, Tuomilehto J, Yu KF, Colman N, Blaner WS et al. 1992. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J. Pediatr. 120:863–71
    [Google Scholar]
  89. 89.  Misselbeck K, Marchetti L, Field MS, Scotti M, Priami C, Stover PJ 2017. A hybrid stochastic model of folate-mediated one-carbon metabolism: effect of the common C677T MTHFR variant on de novo thymidylate biosynthesis. Sci. Rep. 7:797
    [Google Scholar]
  90. 90.  Molloy AM, Kirke P, Hillary I, Weir DG, Scott JM 1985. Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. Arch. Dis. Child. 60:660–65
    [Google Scholar]
  91. 91.  Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M et al. 2009. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 123:917–23
    [Google Scholar]
  92. 92.  Momb J, Lewandowski JP, Bryant JD, Fitch R, Surman DR et al. 2013. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. PNAS 110:549–54
    [Google Scholar]
  93. 93. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131–37
    [Google Scholar]
  94. 94.  Narisawa A, Komatsuzaki S, Kikuchi A, Niihori T, Aoki Y et al. 2012. Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans. Hum. Mol. Genet. 21:1496–503
    [Google Scholar]
  95. 95.  Nilsen H, Stamp G, Andersen S, Hrivnak G, Krokan HE et al. 2003. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 22:5381–86
    [Google Scholar]
  96. 96.  Noguchi H, Prem Veer Reddy G, Pardee AB 1983. Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell 32:443–51
    [Google Scholar]
  97. 97.  Oppenheim EW, Adelman C, Liu X, Stover PJ 2001. Heavy chain ferritin enhances serine hydroxymethyltransferase expression and de novo thymidine biosynthesis. J. Biol. Chem. 276:19855–61
    [Google Scholar]
  98. 98.  Pai YJ, Leung KY, Savery D, Hutchin T, Prunty H et al. 2015. Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. Nat. Commun. 6:6388
    [Google Scholar]
  99. 99.  Palmer AM, Kamynina E, Field MS, Stover PJ 2017. Folate rescues vitamin B12 depletion-induced inhibition of nuclear thymidylate biosynthesis and genome instability. PNAS 114:E4095–102
    [Google Scholar]
  100. 100.  Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C et al. 2006. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur. J. Hum. Genet. 14:768–72
    [Google Scholar]
  101. 101.  Parle-McDermott A, Pangilinan F, Mills JL, Signore CC, Molloy AM et al. 2005. A polymorphism in the MTHFD1 gene increases a mother's risk of having an unexplained second trimester pregnancy loss. Mol. Hum. Reprod. 11:477–80
    [Google Scholar]
  102. 102.  Plucinski TM, Fager RS, Reddy GP 1990. Allosteric interaction of components of the replitase complex is responsible for enzyme cross-inhibition. Mol. Pharmacol. 38:114–20
    [Google Scholar]
  103. 103.  Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA, James SJ 1995. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res 55:1894–901
    [Google Scholar]
  104. 104.  Poon PP, Storms RK 1994. Thymidylate synthase is localized to the nuclear periphery in the yeast Saccharomyces cerevisiae. J. Biol. . Chem 269:8341–47
    [Google Scholar]
  105. 105.  Prem Veer Reddy G 1982. Catalytic function of thymidylate synthase is confined to S phase due to its association with replitase. Biochem. Biophys. Res. Commun. 109:908–15
    [Google Scholar]
  106. 106.  Prem Veer Reddy G, Pardee AB 1980. Multienzyme complex for metabolic channeling in mammalian DNA replication. PNAS 77:3312–16
    [Google Scholar]
  107. 107.  Rassin DK, Gaull GE 1975. Subcellular distribution of enzymes of transmethylation and transsulphuration in rat brain. J. Neurochem. 24:969–78
    [Google Scholar]
  108. 108.  Ratnaike RN 2003. Acute and chronic arsenic toxicity. Postgrad. Med. J. 79:391–96
    [Google Scholar]
  109. 109.  Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C et al. 2007. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 18:362–66
    [Google Scholar]
  110. 110.  Rebekah PK, Tella S, Buragadda S, Tiruvatturu MK, Akka J 2017. Interaction between maternal and paternal SHMT1 C1420T predisposes to neural tube defects in the fetus: evidence from case-control and family-based triad approaches. Birth Defects Res 109:1020–29
    [Google Scholar]
  111. 111.  Reytor E, Pérez-Miguelsanz J, Alvarez L, Pérez-Sala D, Pajares MA 2009. Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution. FASEB J 23:3347–60
    [Google Scholar]
  112. 112.  Rode W, Jastreboff MM, Bertino JR 1985. Thymidylate synthase inhibition in cells with arrested DNA synthesis is not due to an allosteric interaction in the replitase complex. Biochem. Biophys. Res. Commun. 128:345–51
    [Google Scholar]
  113. 113.  Saif MW, Wilson RH, Harold N, Keith B, Dougherty DS, Grem JL 2001. Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. Anti-Cancer Drugs 12:525–31
    [Google Scholar]
  114. 114.  Sankar DV, Geisler A, Rozsa PW 1969. Intracellular distribution of folic acid in mouse liver. Experientia 25:691–92
    [Google Scholar]
  115. 115.  Sano H, Noguchi H, Kodama I, Itoh T 1988. Rapid methylation of genomic DNA in proliferating T-cells from bovine thymocytes. Biochim. Biophys. Acta 950:274–81
    [Google Scholar]
  116. 116.  Santi DV, McHenry CS, Sommer H 1974. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 13:471–81
    [Google Scholar]
  117. 117.  Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res. A Clin. Mol. Teratol. 82:211–16
    [Google Scholar]
  118. 118.  Schirch V, Strong WB 1989. Interaction of folylpolyglutamates with enzymes in one-carbon metabolism. Arch. Biochem. Biophys. 269:371–80
    [Google Scholar]
  119. 119.  Schormann N, Ricciardi R, Chattopadhyay D 2014. Uracil-DNA glycosylases-structural and functional perspectives on an essential family of DNA repair enzymes. Protein Sci 23:1667–85
    [Google Scholar]
  120. 120.  Schrader CE, Guikema JE, Wu X, Stavnezer J 2009. The roles of APE1, APE2, DNA polymerase β and mismatch repair in creating S region DNA breaks during antibody class switch. Philos. Trans. R. Soc. B 364:645–52
    [Google Scholar]
  121. 121.  Scott JM, Weir DG 1980. Drug-induced megaloblastic change. Clin. Haematol. 9:587–606
    [Google Scholar]
  122. 122.  Scotti M, Stella L, Shearer EJ, Stover PJ 2013. Modeling cellular compartmentation in one-carbon metabolism. Wiley Interdiscip. Rev. Syst. Biol. Med. 5:343–65
    [Google Scholar]
  123. 123.  Seiple L, Jaruga P, Dizdaroglu M, Stivers JT 2006. Linking uracil base excision repair and 5-fluorouracil toxicity in yeast. Nucleic Acids Res 34:140–51
    [Google Scholar]
  124. 124.  Shane B, Stokstad EL 1985. Vitamin B12–folate interrelationships. Annu. Rev. Nutr. 5:115–41
    [Google Scholar]
  125. 125.  Sheppard NG, Jarl L, Mahadessian D, Strittmatter L, Schmidt A et al. 2015. The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation. Sci. Rep. 5:15029
    [Google Scholar]
  126. 126.  Shin YS, Chan C, Vidal AJ, Brody T, Stokstad EL 1976. Subcellular localization of γ-glutamyl carboxypeptidase and of folates. Biochim. Biophys. Acta 444:794–801
    [Google Scholar]
  127. 127.  Smithells RW, Sheppard S, Schorah CJ 1976. Vitamin deficiencies and neural tube defects. Arch. Dis. Child. 51:944–50
    [Google Scholar]
  128. 128.  Sommer H, Santi DV 1974. Purification and amino acid analysis of an active site peptide from thymidylate synthetase containing covalently bound 5-fluoro-2′-deoxyuridylate and methylenetetrahydrofolate. Biochem. Biophys. Res. Commun. 57:689–95
    [Google Scholar]
  129. 129.  Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK 1991. Neural-tube defects and derangement of homocysteine metabolism. N. Engl. J. Med. 324:199–200
    [Google Scholar]
  130. 130.  Stover PJ 2004. Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 62:S3–12
    [Google Scholar]
  131. 131.  Strong WB, Schirch V 1989. In vitro conversion of formate to serine: effect of tetrahydropteroylpolyglutamates and serine hydroxymethyltransferase on the rate of 10-formyltetrahydrofolate synthetase. Biochemistry 28:9430–39
    [Google Scholar]
  132. 132.  Strong WB, Tendler SJ, Seither RL, Goldman ID, Schirch V 1990. Purification and properties of serine hydroxymethyltransferase and C1-tetrahydrofolate synthase from L1210 cells. J. Biol. Chem. 265:12149–55
    [Google Scholar]
  133. 133.  Studzinski GP, Shankavaram UT, Moore DC, Reddy PV 1991. Association of c-myc protein with enzymes of DNA replication in high molecular weight fractions from mammalian cells. J. Cell. Physiol. 147:412–19
    [Google Scholar]
  134. 134.  Suarez L, Hendricks K, Felkner M, Gunter E 2009. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Birth Defects Res. A Clin. Mol. Teratol. 85:574–81
    [Google Scholar]
  135. 135.  Subramanyam C, Honn SC, Reed WC, Reddy GP 1990. Nuclear localization of 68 kDa calmodulin-binding protein is associated with the onset of DNA replication. J. Cell. Physiol. 144:423–28
    [Google Scholar]
  136. 136.  Suh JR, Herbig AK, Stover PJ 2001. New perspectives on folate catabolism. Annu. Rev. Nutr. 21:255–82
    [Google Scholar]
  137. 137.  Tibbetts AS, Appling DR 2010. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30:57–81
    [Google Scholar]
  138. 138.  Touzot F, Hacein-Bey-Abina S, Fischer A, Cavazzana M 2014. Gene therapy for inherited immunodeficiency. Expert Opin. Biol. Ther. 14:789–98
    [Google Scholar]
  139. 139.  Tsang BL, Devine OJ, Cordero AM, Marchetta CM, Mulinare J et al. 2015. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies. Am. J. Clin. Nutr. 101:1286–94
    [Google Scholar]
  140. 140. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW et al. 2017. Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force Recommendation Statement. JAMA 317:183–89
    [Google Scholar]
  141. 141.  van den Donk M, Pellis L, Crott JW, van Engeland M, Friederich P et al. 2007. Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas. J. Nutr. 137:2114–20
    [Google Scholar]
  142. 142.  van der Wilt CL, Backus HH, Smid K, Comijn L, Veerman G et al. 2001. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. Cancer Res 61:3675–81
    [Google Scholar]
  143. 143.  Veer Reddy GP, Pardee AB 1983. Inhibitor evidence for allosteric interaction in the replitase multienzyme complex. Nature 304:86–88
    [Google Scholar]
  144. 144.  Visentin M, Diop-Bove N, Zhao R, Goldman ID 2014. The intestinal absorption of folates. Annu. Rev. Physiol. 76:251–74
    [Google Scholar]
  145. 145.  Viswanathan M, Treiman KA, Kish-Doto J, Middleton JC, Coker-Schwimmer EJ, Nicholson WK 2017. Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 317:190–203
    [Google Scholar]
  146. 146.  Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J et al. 2013. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet 381:1029–36
    [Google Scholar]
  147. 147.  Wang YC, Lin WL, Lin YJ, Tang FY, Chen YM, Chiang EP 2014. A novel role of the tumor suppressor GNMT in cellular defense against DNA damage. Int. J. Cancer 134:799–810
    [Google Scholar]
  148. 148.  Watkins D, Schwartzentruber JA, Ganesh J, Orange JS, Kaplan BS et al. 2011. Novel inborn error of folate metabolism: identification by exome capture and sequencing of mutations in the MTHFD1 gene in a single proband. J. Med. Genet. 48:590–92
    [Google Scholar]
  149. 149.  Weir DG, Keating S, Molloy A, McPartlin J, Kennedy S et al. 1988. Methylation deficiency causes vitamin B12-associated neuropathy in the pig. J. Neurochem. 51:1949–52
    [Google Scholar]
  150. 150.  Werbrouck BF, Pauwels WJ, De Bleecker JL 2008. A case of 5-fluorouracil-induced peripheral neuropathy. Clin. Toxicol. 46:264–66
    [Google Scholar]
  151. 151.  Wilson A, Platt R, Wu Q, Leclerc D, Christensen B et al. 1999. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol. Genet. Metab. 67:317–23
    [Google Scholar]
  152. 152.  Woeller CF, Anderson DD, Szebenyi DM, Stover PJ 2007. Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway. J. Biol. Chem. 282:17623–31
    [Google Scholar]
  153. 153.  Wolff T, Witkop CT, Miller T, Syed SB 2009. Folic acid supplementation for the prevention of neural tube defects: an update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 150:632–39
    [Google Scholar]
  154. 154.  Wong NA, Brett L, Stewart M, Leitch A, Longley DB et al. 2001. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Br. J. Cancer 85:1937–43
    [Google Scholar]
  155. 155.  Yadav U, Kumar P, Yadav SK, Mishra OP, Rai V 2015. Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab. Brain Dis. 30:7–24
    [Google Scholar]
  156. 156.  Yan L, Zhao L, Long Y, Zou P, Ji G et al. 2012. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. PLOS ONE 7:e41689
    [Google Scholar]
  157. 157.  Yang Y, Chen J, Wang B, Ding C, Liu H 2015. Association between MTHFR C677T polymorphism and neural tube defect risks: a comprehensive evaluation in three groups of NTD patients, mothers, and fathers. Birth Defects Res. A Clin. Mol. Teratol. 103:488–500
    [Google Scholar]
  158. 158.  Yarbro JW 1992. Mechanism of action of hydroxyurea. Semin. Oncol. 19:1–10
    [Google Scholar]
  159. 159.  Yeo EJ, Wagner C 1994. Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver. PNAS 91:210–14
    [Google Scholar]
  160. 160.  Zamierowski M, Wagner C 1974. High molecular weight complexes of folic acid in mammalian tissues. Biochem. Biophys. Res. Commun. 60:81–87
    [Google Scholar]
  161. 161.  Zhang T, Lou J, Zhong R, Wu J, Zou L et al. 2013. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLOS ONE 8:e59570
    [Google Scholar]
  162. 162.  Zhang T, Xin R, Gu X, Wang F, Pei L et al. 2009. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr 12:680–86
    [Google Scholar]
  163. 163.  Zhao R, Diop-Bove N, Visentin M, Goldman ID 2011. Mechanisms of membrane transport of folates into cells and across epithelia. Annu. Rev. Nutr. 31:177–201
    [Google Scholar]
  164. 164.  Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman ID 2009. A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis. J. Biol. Chem. 284:4267–74
    [Google Scholar]
/content/journals/10.1146/annurev-nutr-071714-034441
Loading
/content/journals/10.1146/annurev-nutr-071714-034441
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error